Skip to content

Clinical trials

Hypertension, Pulmonary trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Country / region: Germany Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20042
20056
20061
20076
20086
200910
201011
20117
20122
20132
20149
20156
20167
20178
20187
20195
20207
20218
20224
20236
20245
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed72
Terminated22
Unknown status15
Recruiting13
Active, not recruiting7
Enrolling by invitation3
Withdrawn3
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer21
Heidelberg University13
University of Giessen13
Novartis Pharmaceuticals7
United Therapeutics7
Actelion6
GlaxoSmithKline5
Hannover Medical School4
Biogen3
Gilead Sciences3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary136
Pulmonary Arterial Hypertension48
Heart Failure11
Familial Primary Pulmonary Hypertension8
Lung Diseases, Interstitial7
Connective Tissue Diseases5
Cardiovascular Diseases4
Hypertension4
Lung Diseases4
Pulmonary Disease, Chronic Obstructive4

Trials

Showing 26 to 50 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.